GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton Dickinson & Co (FRA:BOX) » Definitions » ROE % Adjusted to Book Value

Becton Dickinson (FRA:BOX) ROE % Adjusted to Book Value : 1.59% (As of Dec. 2023)


View and export this data going back to 1963. Start your Free Trial

What is Becton Dickinson ROE % Adjusted to Book Value?

Becton Dickinson's ROE % for the quarter that ended in Dec. 2023 was 4.35%. Becton Dickinson's PB Ratio for the quarter that ended in Dec. 2023 was 2.74. Becton Dickinson's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 1.59%.


Becton Dickinson ROE % Adjusted to Book Value Historical Data

The historical data trend for Becton Dickinson's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton Dickinson ROE % Adjusted to Book Value Chart

Becton Dickinson Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.90 1.37 2.93 3.00 1.85

Becton Dickinson Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.76 2.70 2.15 0.56 1.59

Competitive Comparison of Becton Dickinson's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Becton Dickinson's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton Dickinson's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Becton Dickinson's ROE % Adjusted to Book Value falls into.



Becton Dickinson ROE % Adjusted to Book Value Calculation

Becton Dickinson's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.59% / 3.02
=1.85%

Becton Dickinson's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=4.35% / 2.74
=1.59%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Becton Dickinson ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Becton Dickinson's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton Dickinson (FRA:BOX) Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.